# Add-on Simvastatin in Schizophrenia Trial

> **NCT00605995** · NA · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 15 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00605995
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Enrollment was slower than anticipated by the investigators and the funding research foundation.
- **Last updated:** 2017-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605995, "Add-on Simvastatin in Schizophrenia Trial". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00605995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*